Q1 FY27 saw robust growth with revenue up 31.8% and PAT up 75.5% year-over-year, driven by strong performance across all segments. Margin expansion, capacity investments, and ongoing innovation support a positive outlook despite geopolitical and market uncertainties.Original document: Srf Limited…
Record revenue and TRASM growth were achieved, with liquidity reaching $824M and EBITDAR margin at 16.3%. International expansion and disciplined capacity drove strong results, while net loss widened due to higher costs. FY'26 outlook remains positive with moderated capacity growth.Original documen…
Infleqtion (NYSE: INFQ), a global leader in quantum computing and quantum sensing powered by neutral-atom technology, announced it has been awarded three projects to accelerate American scientific research and innovation by the U.S. Department of Energy (DOE) for the Genesis Mission. The projects i…
Fiscal 2026 saw a sharp revenue decline due to industry oversupply and low egg prices, but strategic acquisitions and investments in specialty and prepared foods drove diversification and resilience. Prepared foods and specialty eggs now comprise over half of net sales, with significant capacity ex…
RNS Number : 4615N Goldman Sachs Asset Management LP 22 July 2026 FORM 8.3PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BYA PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the "Code")1. KEY INFORMATION2. POSITIONS OF THE…
Strong Q2 results featured net interest margin expansion to 3.07%, 21% annualized net interest income growth, and a 17% annualized increase in tangible book value. Loan growth was disciplined at 5.4% annualized, with multifamily and affordable housing as key drivers. Expenses are expected to remain…
WSW, NY, July 22nd, 2026, FinanceWireTen billion dollars. That is what Vertex Pharmaceuticals (Nasdaq: VRTX) agreed to pay on July 6, 2026, to acquire Crinetics Pharmaceuticals (Nasdaq: CRNX) at $85.00 per share, roughly a 101% premium to the prior close.Consider what Vertex is buying: PALSONIFY, t…
Core operating earnings rose 14.6% year-over-year to $2.8 billion, with strong P&C underwriting, investment, and life income results. Diversified growth, disciplined underwriting, and robust capital management offset softening market conditions and rising loss costs.Based on Chubb Limited [CB] Q2 2…
Q3 delivered strong double-digit sales and EPS growth, driven by AI, data, and power trends, with record orders and backlog supporting robust guidance for FY26 and FY27. Strategic acquisitions and investments in connectivity and power further strengthen growth prospects.Based on TE Connectivity plc…
RNS Number : 4613N Mackenzie Financial Corporation 22 July 2026 Ap27FORM 8.3IRISH TAKEOVER PANELOPENING POSITION DISCLOSURE/DEALING DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVERRULES, 2022 BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE1…
Second quarter results showed strong organic fee growth, positive operating leverage, and robust capital returns, aided by a $525M Visa gain and disciplined cost management. Wealth and asset servicing segments delivered double-digit growth, while guidance for full-year revenue and NII was raised to…
Q1 FY 2027 delivered record revenue, profitability, and order book, with EBITDA margin at 23.25% and export revenue surging. FY 2027 revenue growth guidance raised to 40%, supported by robust demand in optical fiber, data center, and defense segments.Based on HFCL Limited [HFCL] Q1 26/27 Audio Tran…
Revised summary: The conference highlighted rapid progress at the Barrambie Gold Project, with production targeted soon via a low-capital joint venture, and significant advancement of the Utah lithium-potash brine project. Near-term catalysts include mining approvals, resource estimates, and metall…
Q2 2026 saw record revenue and strong growth in volumes, open interest, and market data, with continued innovation in product offerings such as 24/7 trading and new futures products. Institutional clients drove 94% of volume, while retail and new product segments also expanded.Based on CME Group In…
RNS Number : 4612N M&G PLC 22 July 2026 FORM 8.3PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BYA PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the "Code")1. KEY INFORMATION2. POSITIONS OF THE PERSON MAKING THE DISCLOS…
Record adjusted net income and stable margins were driven by strong loan growth and successful acquisition integrations. The announced Finward Bancorp deal will expand the regional footprint and is expected to be accretive to earnings. Tangible book value and capital ratios remain strong.Based on F…
Second quarter and first half results showed strong revenue, EBITDA, and EPS growth, supported by robust travel demand and strategic acquisitions. Raised full-year guidance, with acquisitions expected to be immediately accretive and further expand the owner base.Based on Travel Leisure Co. [TNL] Q2…
RNS Number : 4465N BlackRock Group 22 July 2026 FORM 8.3PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BYA PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the "Code")1. KEY INFORMATION2. POSITIONS OF THE PERSON MAKING THE…
RNS Number : 3980N Syquant Capital 22 July 2026 Ap19FORM 8.3IRISH TAKEOVER PANELDISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE1. KEY INFORMATION2. INTERESTS AND…
NORTHAMPTON, MA / ACCESS Newswire / July 22, 2026 / AEG employees came together on July 19 to participate in the 2026 Long Beach Legacy Triathlon, raising more than $18,000 in support of Children's Hospital Los Angeles (CHLA). The funds will help advance critical pediatric cancer research, treatmen…
